Skip to main content
. 2021 Apr 1;22(7):3676. doi: 10.3390/ijms22073676
ACh Acetylcholine
DMSO Dimethyl sulfoxide
DNA Deoxyribonucleic acid
EMA European Medicines Agency
FDA Food and Drug Administration
HeLa Cervical adenocarcinoma
IC50 Half maximal inhibitory concentration
ID50 Compound concentration inhibiting by 50% the tumor-cell viability
IL-1β Interleukin 1 beta
IL-6 Interleukin 6
MDA-MB-231 Triple-negative breast cancer
miRNA-27 Microrna
mRNA Messenger RNA
MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide
PBMC Peripheral mononuclear blood cells
PBS Phosphate-buffered saline
PT Pentacyclic triterpenoids
ROS Reactive oxygen species
SP Specificity protein
SREBP Sterol regulatory element-binding proteins
TNF-α Tumor Necrosis Factor-α
TPP Triphenylphosphonium
VEGFR Vascular endothelial growth factor